Neutrons, like X-and gamma-rays, are uncharged and cause ionization via secondary particles. However, most of the ionization in tissue irradiated with neutrons (of energies in the region of a few MeV) results from secondary protons, in contrast with the electrons which arise from Xor gamma-irradiation. The density of ionization is generally much greater along the tracks of these heavier particles, so that neutrons dissipate more energy at a higher linear energy transfer (LET) than Xor gamma-rays.
Neutrons, like X-and gamma-rays, are uncharged and cause ionization via secondary particles. However, most of the ionization in tissue irradiated with neutrons (of energies in the region of a few MeV) results from secondary protons, in contrast with the electrons which arise from Xor gamma-irradiation. The density of ionization is generally much greater along the tracks of these heavier particles, so that neutrons dissipate more energy at a higher linear energy transfer (LET) than Xor gamma-rays.
The radiobiological properties of high and low LET radiations are rather different, and may be illustrated in terms of survival curves. Fig 1 shows typical survival curves for cells irradiated with X-rays or neutrons, and illustrates two general features:
(1) The slope of the curve for irradiation with neutrons is generally greater than that for X-rays, so that the relative biological effectiveness (RBE) for neutrons is greater than that for X-rays. (The RBE is defined as the ratio of the dose of X-rays to that of neutrons to produce a given level of injury.)
(2) The curve for X-rays extrapolates to a greater value than that for neutrons. This difference in shape between the two curves in the low dose region implies a greater capacity for repair of sublethal damage after X-rays than after neutrons but in practical terms means that the RBE for fast neutrons increases as the dose decreases (Fowler & Morgan 1963) .
In order to examine the relationship between RBE and dose, an analysis was made of tissues irradiated with neutrons on the MRC cyclotron at Hammersmith Hospital. The neutrons are produced by 16 MeV deuterons on beryllium and have a mean energy of about 7.5 MeV. It is difficult to make a direct comparison with data from other sources, because absolute dosimetry with neutrons is not yet very precise and because the quality of beams may differ. Fig 2 shows the relationship between RBE and dose per fraction for skin damage. It is seen that the RBE increases with decreasing dose as expected from survival curve considerations (Fig 1) and does not vary greatly between species. The small increase in RBE seen for doses greater than about 1500 rads of neutrons is probably due to a very small proportion of hypoxic cells in the skin of anesthetized animals. Plotting the logarithm of RBE against the logarithm of dose per fraction converts this curve into a straight line. Data are shown for damage to the intestinal mucosa, skin, cartilage, and heemopoietic tissues in (Reproducedfrom Field & Hornsey 1971, by kindpermission) are different for these four tissues, an important fact of which the radiotherapist should be fully awart.
The third major difference between the effects of neutrons and X-rays is the magnitude of the oxygen effect (Gray et al. 1953) . If cells or tissues are made hypoxic, then the dose of radiation must be increased to produce the same level of damage as in a well-oxygenated system. The factor by which the dose must be increased is called the oxygen enhancement ratio (OER). For X-rays the OER is usually between 2 and 3, whereas for neutrons it is less by a factor of about 1.5-2.0.
The main rationale for neutron therapy lies in this reduction in the magnitude of the oxygen effect. It seems likely that there are cells in at least some human tumours which are protected from X-rays by hypoxia, and which might be the focus of a recurrence after radiotherapy. Because of the reduced protection by hypoxia against high LET . .% 24 3-0ñ I ft^ radiations, neutrons might be more effective in sterilizing these cells and thereby reduce the number of such recurrences. A further possible reason for using neutrons was pointed out by Alper (1972) . Since the RBE is different for different tissues, then regardless of the oxygen effect, certain tumours might have a high RBE relative to the normal tissues which limit their treatment, and would be better treated with neutrons. Of course, the opposite could also be true, so that a good deal of experimental work is required to determine the RBE as a function of dose per fraction for a wide range of tumours and normal tissues.
The Early Clinical Trical
In 1938, soon after the first cyclotron was working, and before any rationale for the use of fast neutrons in radiotherapy, Stone used neutrons in the treatment of malignant disease. In 1948 he reported that the late reactions he observed were more severe than he expected on the basis of the early reactions, and further radiotherapy with fast neutrons was abandoned for almost 20 years.
A considerable effort has been made at Hammersmith to investigate the relationship between early and late damage. Pigs with irradiated skin have been kept for many years, but the RBE for late damage has not been found to be different from that for early damage, either for singlo or fractionated courses of treatment (Bewley et al. 1967) . With rat and mouse skin similar observa- tions have also been made, and it is clear that the relationship between early and late damage is not different for X-rays or neutrons or for different treatment regimes up to 15 fractions given in 3 weeks (Field 1969a, Field & Fowler, unpublished) . In all cases there is a dose threshold, below which there is virtually no late reaction following a considerable early reaction. Any increase in dose above this threshold level results in only a small increase in -early damage, but a very large corresponding increase in late damage (Fig 4) . These authors calculated the equivalent dose of X-rays received by each of Stone's patients, and although it is not possible from the records to determine which factors played the major role, it seems sufficient to note that all patients who developed late necrosis received an excessive dose of radiation.
The Ellis Formula
For X-rays, Ellis (1969) has suggested using the empirical relationship between total dose TD, number of fractions N, and overall treatment timeT: TD = NSD No24 TO-1 where NSD = nominal standard dose for X-rays This formula has been found to be particularly useful in the trial of fast neutrons at Hammersmith Hospital, where non-standard fractionation schedules are in use. A modified formula has been adopted for neutrons, based on animal data (Field 1971) :
TD=NSDn N0 04 TO 11 where NSDn=nominal standard dose for neutrons
The exponent for T is unchanged. This is because the T factor probably refers to cellular proliferation during the course of treatment, and there is no evidence that this is different after neutron treatments. The exponent for N is smaller because of the reduction in capacity to repair sublethal damage after neutron treatments, as reflected in the reduction in width of the shoulder of the survival curve (Fig 1) .
Radiotherapy with Animals
In order to test whether neutrons are more effective than X-rays, two experimental systems have been used with single and fractionated doses and have yielded contrasting results. The first tumour was the sarcoma RIB5 in the rat (Field et al. 1968 ). In this tumour the endpoint taken was that of delay in growth of the tumour to reach a certain size after treatment. The second tumour was the C3H mouse mammary carcinoma, and the endpoint used was the proportion of tumours locally controlled (Fowler et al. 1972) . In both experiments the reactions of the normal tissues of the feet of similar animals were used for comparison. Fig 5 illustrates the effects of different treatments on the rat sarcoma. The ideal treatment is one which produces a large effect on the tumour with a correspondingly small skin reaction. With this tumour, known to contain a proportion of cells protected from irradiation by hypoxia (Thomlinson & Craddock 1967) , the worst form of treatment was a single dose of X-rays. Because Fowler et al. 1972, by kindpermission) of reoxygenation (i.e. an improvement in the oxygen status of hypoxic cells) between fractions (Thomlinson 1971), 2 fractions and 5 fractions of X-rays were more effective than a single dose, but in all cases treatment with neutrons was most effective. Fig 6 illustrates the experimental results in the CsH carcinoma. This tumour, which shrinks rapidly after irradiation, has also been shown to reoxygenate more rapidly and more extensively than the RIBs sarcoma (Howes 1969) . It is seen that in this case 5 fractions of X-rays in 9 days was as effective as any of the neutron treatments, but that the optimum choice of treatment with X-rays was more critical than that with neutrons.
These animal experiments suggest, therefore, two possibilities. First, that some tumours, like RIB5, might always be more effectively treated with neutrons. This will apply to tumours which do not reoxygenate adequately between fractions, so that hypoxic cells always play a significant role in determining the response of the tumour. Secondly, some tumours might be equally well treated with Xor gamma-rays or neutrons, providing sufficient is known about such tumours to select the optimum fractionation scheme with X-or gamma-rays. Since such information is not available at the present time, even for animal tumours, it is perhaps safer to rely on fast neutrons. 1938 to 1943 (Stone et al. 1940 , Stone & Larkin 1942 , Stone 1948 . Over 200 patients with very advanced tumours were treated and some surprisingly good results were obtained. However, by 1948 it was apparent that the cures were at the expense of very severe damage to the normal tissues and the trial was therefore abandoned. The reasons for these unacceptably severe reactions were found later (see Field 1972) . These and other radiobiological data constitute the basis for the new trial of fast neutrons which is now being con-ducted on the MRC cyclotron at Hammersmith Hospital.
Details of the preliminary work and the methods used to compare the effects of neutrons with orthovoltage X-rays on skin and superficial tumours have already been published (Catterall et al. 1971) . The relative biological effectiveness (RBE) for fast neutrons for skin was found to be 3.0 for the doses used, which were 120 rads per fraction, and a clinically significant skin sparing effect was demonstrated. However, skin reactions are produced and these proceed to moist desquamation in some areas of the body. All these reactions heal satisfactorily 24 weeks after the end of treatment.
Treatment is given on Mondays, Wednesdays and Fridays and 10-15 patients can be treated per session. The standard dose is 1440 rads in 12 fractions over 4 weeks. Taking the RBE for skin as 3.0 and using the Ellis formula for gamma-rays and a modification of this for neutrons, this standard dose is equivalent to 6300 rads of gamma-rays given in 30 fractions over 40 days. When, for clinical reasons or for the regular maintenance periods of the cyclotron, the treatment time has to be extended over a longer period, the modified Ellis formula is used and the total dose is increased according to the time and number of fractions, for example 1560 rads are given in 18 fractions over 40 days. 
